Lightcalls.com
 

Politics. The giant medical/pharmac...

Politics. The giant medical/pharmaceutical lobbies. Irrational fears. Bias. Misinformation. Just plain ignorance. These factors must be what's at play behind sum of two units recent articles by Gina Kolata in The fresh York Times (June 17 and June 18 1996)

In the titles and headings, alone, we have: "On Fringes of Health Care, Untest Therapies Thrive"; "A Reliance in succession Anecdotes"; "Natural Healing, or Quackery?" "In inquirys Outside Mainstream, Medical Projects Rewrite Rules"; and "Advising the Public upon Risky Therapies"labels and questions that are clearly loaded with negative associations and rife with journalistic (and philosophical) bias. Let's await at just one of the more misinformed/biased remarks: "On Fringes of Health Care, Untest Therapies Thrive": Can't be safe what Ms. Kolata is referring to here.

Fringes? About 1619 years ago, Hippocrates, the father of recent "conventional" medicine, embraced concepts closer to the principles of homeopathy (e.g., like method of treatments like) than the the "drug `em and forget `em" approach popular with many of the so-called "orthodox" or "mainstream" physicians. Homeopathy also has correlaries in naturopathic medicine, which began with the revereed European nature-cure movement of the nineteenth hundred Ayurvedic Medicine, Tibetan Medicine and Traditional Chinese Medicine are orthodox medicine for billions of population today. An unsophisticated drug-happy Western physician would be considered the quack in societies which venerate the wisdom, and efficacy, of these ancient medical methods Therefore, if anything, so-called "orthodox" medicine is upon the fringe of health care methods which were helping people thousands of years before it was level on the scene.



Untested? Vitamins, minerals, and other natural mingles are also the subjects of rigorous scientific analysis and clinical investigation, with centurys of studies each year examining the drifts of vitamins and vitamin-like combines (such as A, C, E the carotenoids, flavonoids, alpha-lipoic acid, etc) minerals (selenium, for example), and various nutriment compounds, not to mention treatment modalities.

Why worry? As industry analyst and veteran journalist, Peter Barry Chowka, pointed without in a July 9th letter: "The fresh York Times' enormous influence as the `newspaper of record' makes these articles a cause for pertain to The timing seems ironic forward the heels of two prosperous alternative medicine conferences in the nation's capital [] and the imminent [approval] of the Access to Medical Treatment Act by dint of the U.S. Congress."

The mainstreaming of credible complementary medicine must happen. I encourage you all to write The of the present day York Times and let them know for what cause much respect we have for natural medicine and natural harvests and how little tolerance we have for inaccurate reporting.

In pious health!

COPYRIGHT 1996 PRIMEDIA Intertec, a PRIMEDIA Company. All Rights Reserved

COPYRIGHT 2004 Gale Group



Other Articles
 -Morphotek will collaborat...
 -Eksigent Technologies nam...
 -The benefits of outsourci...
 -Sartorius Corporation ...
 -In our previous column, w...
 -Efoora appointed Michael ...
 -Affymax appointed Anne-Ma...
 -Traditionally, continuous...
 -New Brunswick Scientific ...
 -The German-American firm ...
 -Don G. Burstyn, formerly ...
 -American patients are mor...
 -Summary Prior to va...
 -BioPharm Editorial Adviso...
 -Australia agreed to spend...
 -The Biotechnology Industr...
 -Ambion, The RNA Company i...
 -Therapies based on living...
 -A recent survey found tha...
 -ViroLogic will acquire Ac...
 -Cardinal Health named Joh...
 -One of the greatest chall...
 -As the president of a sma...
 -Sweden-based Biovitrum wi...
 -Nanogen appointed David L...
 -The Experion Process Know...
 -Although biomedical resea...
 -The Supreme Court of Cana...
 -Netherlands-based DSM Bio...
 -David A. Smoller joined S...
 -A few months ago, I wrote...
 -Panacos Pharmaceuticals w...
 -Karen K. Vaccaro will res...
 -Acceleron Pharma appointe...
 -Two quarterly meetings of...
 -Illinois-based Abbot Labo...
 -FKI Logistics announced t...
 -The following corrections...
 -It its widest definition,...
 -UK-based Xcellsyz will li...
 -Andrew P. Aromando joined...
 -Invitrogen's comprehensiv...
 -Last month, we described ...
 -The Swiss life sciences c...
 -Protein Design Labs (PDL)...
 -Model It HNMR, the newest...
 -Tech transfer, like chang...
 -QLT and Atrix Laboratorie...
 -Dendreon announced Christ...
 -Baxter Pharmaceutical Sol...
 -The biopharmaceutical ind...
 -GlaxoSmithKline announced...
 -Montreal-based Caprion Ph...
 -Xenova Group recently ann...
 -Cole-Parmer's new 192-pag...
 -Over the last decade ther...
 -Benchmark your facility p...
 -As biotechnology organiza...
 -Frederick D. Sancillo, fo...
 -Insmed acquired a recombi...
 -Baxter Pharmaceutical Sol...
 -Model It HNMR, the newest...
 -DA's regulation 21 CFR Pa...
 -Robert P. Ryan joined Ath...
 -A new report from Busines...
 -Biotest offers a complete...
 -Swagelok offers a brochur...
 -Partnering is a global ph...
 -Human Genome Sciences CEO...
 -Shorten the process devel...
 -The licensure of biotechn...
 -Rodger Currie joined Amge...
 -The GEA Filtration Model ...
 -A multi-channel chemistry...
 -From June 6-9, San Franci...
 -Skanska USA Building Inc....
 -New Brunswick Scientific'...
 -AVI BioPharma appointed P...
 -Ambion, The RNA Company, ...
 -"If you want to be a...
 -Xcellerex appointed Susan...
 -Researchers identified th...
 -Cool Spring Business Park...
 -In October 2003, Shenzhen...
 -Laureate Pharma appointed...
 -After a 6-5 vote by Calif...
 -QSourcing, a service of Q...
 -The recent discovery of &...
 -Affymax added Douglas L. ...
 -USDA recently approved tw...
 -BioPharm International is...
 -Serologicals has released...
 -This document by Shenzhen...
 -Robert Bronstein joined A...
 -Gloucester Gains Fujisawa...
 -With more than 30 years o...
 -Pall's SUPRAdisc II depth...
 -In today's competitive ma...
 -Protein Design Labs repor...
 -Charles A. Rice will repl...
 -AstraZeneca's Faslodex (f...
.
© 2006 Lightcalls.com All rights reserved.